We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-1.36%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.32B
AUM Growth
-$280M
Cap. Flow
-$198M
Cap. Flow %
-15.04%
Top 10 Hldgs %
17.04%
Holding
1,626
New
448
Increased
346
Reduced
313
Closed
483

Top Buys

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$9.86M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$9.7M
3
CNR
Core Natural Resources Inc
CNR
+$8.26M
4
BIO icon
Bio-Rad Laboratories Class A
BIO
+$6.63M
5
ORCL icon
Oracle
ORCL
+$6.25M

Top Sells

Rank Stock Value
1
SMAR
Smartsheet Inc.
SMAR
+$14M
2
HTLF
Heartland Financial USA, Inc.
HTLF
+$11.1M
3
NVDA icon
NVIDIA
NVDA
+$9.36M
4
AMZN icon
Amazon
AMZN
+$8.75M
5
NFLX icon
Netflix
NFLX
+$8.58M

Sector Composition

Rank Sector Weight
1 Technology 13.2%
2 Healthcare 10.48%
3 Consumer Discretionary 9.93%
4 Financials 7.26%
5 Communication Services 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRRK icon
326
Scholar Rock
SRRK
$6.22B
$927K 0.07%
28,844
+4,900
+20% +$189K
AMT icon
327
American Tower
AMT
$79B
$925K 0.07%
+4,251
New +$834K
ISRG icon
328
Intuitive Surgical
ISRG
$138B
$924K 0.07%
1,866
+236
+14% +$131K
PYCR
329
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
$922K 0.07%
+41,096
New +$909K
BYD icon
330
Boyd Gaming
BYD
$5.92B
$919K 0.07%
13,957
-1,381
-9% -$101K
WEX icon
331
WEX
WEX
$6.36B
$915K 0.07%
+5,829
New +$960K
VRDN icon
332
Viridian Therapeutics
VRDN
$2.61B
$912K 0.07%
+67,669
New +$1.15M
GME icon
333
GameStop
GME
$8.59B
$911K 0.07%
40,797
+30,797
+308% +$807K
SJT
334
CALL
San Juan Basin Royalty Trust
SJT
$124M
$907K 0.07%
+164,000
New +$773K
USFR icon
335
WisdomTree Floating Rate Treasury Fund
USFR
$18.4B
$906K 0.07%
18,000
– –
IRON icon
336
Disc Medicine
IRON
$2.98B
$903K 0.07%
18,200
+44
+0.2% +$2.45K
Z icon
337
Zillow
Z
$7.55B
$901K 0.07%
+13,147
New +$1M
ABT icon
338
Abbott
ABT
$188B
$900K 0.07%
6,785
+3,872
+133% +$493K
COKE icon
339
Coca-Cola Consolidated
COKE
$12.6B
$896K 0.07%
6,640
+2,050
+45% +$276K
BRSL
340
Brightstar Lottery PLC
BRSL
$2.03B
$886K 0.07%
54,517
+2,350
+5% +$40.6K
WVE icon
341
Wave Life Sciences
WVE
$1.2B
$883K 0.07%
+109,330
New +$1.2M
ALK icon
342
Alaska Air
ALK
$5.36B
$879K 0.07%
17,860
+2,594
+17% +$170K
SRDX
343
DELISTED
Surmodics
SRDX
$876K 0.07%
28,704
-52,741
-65% -$1.78M
MITK icon
344
Mitek Systems
MITK
$820M
$876K 0.07%
106,200
+84,716
+394% +$824K
DV icon
345
DoubleVerify
DV
$2.03B
$872K 0.07%
65,233
+21,228
+48% +$393K
HHH icon
346
Howard Hughes
HHH
$3.89B
$872K 0.07%
+11,770
New +$889K
NXPI icon
347
NXP Semiconductors
NXPI
$59.3B
$872K 0.07%
+4,587
New +$978K
FOXA icon
348
Fox Class A
FOXA
$26.7B
$870K 0.07%
15,373
-4,311
-22% -$228K
MAG
349
DELISTED
MAG Silver
MAG
$869K 0.07%
56,862
-2,147
-4% -$33.3K
PI icon
350
Impinj
PI
$5.45B
$851K 0.06%
+9,386
New +$1.05M
12 13
14
15 16

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Prelude Capital Management held 1,626 positions worth $1.32B, down 18% from $1.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Prelude Capital Management withdrew a net $198M in Q1 2025, closing 483 positions and reducing 313 holdings. Its most notable exit was Smartsheet Inc., an estimated $14M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in Intra-Cellular Therapies Inc. worth $10.4M.

  • Prelude Capital Management's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 79,142 shares worth $10.4M.
  • Prelude Capital Management added most to Alphabet (Google) Class A in Q1 2025, an estimated $9.7M increase.
  • Prelude Capital Management's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $9.36M.
  • Prelude Capital Management fully exited Smartsheet Inc. in Q1 2025, selling an estimated $14M.
  • Prelude Capital Management's ten largest holdings make up 17% of its $1.32B portfolio in Q1 2025.
  • Prelude Capital Management opened 448 new positions and closed 483 in Q1 2025.
  • Prelude Capital Management's portfolio value fell 18% quarter-over-quarter to $1.32B.

Based on Prelude Capital Management's 13F filing for Q1 2025, filed 15 May 2025.